P3.07-08 Pain Management in Lung Cancer

Abstract

Lung cancer is one of the most prevalent cancers worldwide and pain is its most common symptom. Pain can be brought about by several causes including local invasion of chest structures, metastatic disease or can also be a consequence of treatment. An active multidisciplinary approach is required to manage pain in patients with lung cancer It is a cross-sectional study of 166 patients with lung cancer. We used the BPI “Brief pain inventory`` to assess pain prevalence, intensity and impact on quality of life. Adequacy of pain management was evaluated by the Pain Management Index (PMI) We interviewed 166 patients with bronchogenic carcinoma, 163 men and 3 women. 116 with adenocarcinoma and 50 with epidermoid carcinoma. 80 (42.2%) of our patients have pain. Among them, 7 report low pain and 73 moderate to severe pain (91%). 149 (89,7%) patients have metastasis. The association between the intensity of pain and metastasis was statistically significant (p<0,001). 21 patients (26.2%) are treated with antalgic. 18 with the second level and 3 with the third level. The Pain Management Index (PMI) is negative in 63 patients (81.2%). There is also a statically significant correlation between the intensity of pain and the degradation of each quality of life parameter. Pain management still remains a challenge. This deficiency is due to the inadequate medical training and the unavailability of most third level of analgesics in ambulatory prescription.